Kamada (KMDA) Free Cash Flow (2012 - 2026)

Kamada (KMDA) posted quarterly Free Cash Flow of $682000.0 for Q1 2026, down 28.59% year-on-year from $955000.0 in Q1 2025, and down 86.48% on a QoQ basis from $5.0 million in Q4 2025.

Kamada (KMDA) Free Cash Flow (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Free Cash Flow for 15 consecutive years, with $682000.0 the latest figure, recorded in Q1 2026.

  • Quarterly Free Cash Flow fell 28.59% year-over-year to $682000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.8 million (down 41.3% YoY) and the FY2025 annual result came in at $35.3 million, down 22.57% from the prior year.
  • Free Cash Flow retreated to $682000.0 in Q1 2026 per KMDA's latest filing, from $5.0 million in the prior quarter.
  • Over the last five years, Free Cash Flow for KMDA reached as high as $24.3 million in Q3 2024 and fell as low as -$1734.0 in Q1 2023.
  • A 5-year average of $6.6 million and a median of $5.0 million in 2025 frame the typical range for Free Cash Flow.
  • Annual changes were most pronounced in 2023 — Free Cash Flow plunged 100.03% — and 2024, when it jumped 213594.81%.
  • Year by year, Free Cash Flow stood at $983742.0 in 2022, then soared by 455.43% to $5.5 million in 2023, then soared by 54.52% to $8.4 million in 2024, then tumbled by 40.27% to $5.0 million in 2025, then slumped by 86.48% to $682000.0 in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods registered $682000.0, $5.0 million, and $14.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -208.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 291.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -373.37 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 363.70 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 348.40 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 144.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -38.00 Mn
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn 682,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 682,000.00
Mar 31, 2026 682,000.00
Dec 31, 2025 5.04 Mn
Dec 31, 2025 5.04 Mn
Sep 30, 2025 14.01 Mn
Sep 30, 2025 14.01 Mn
Jun 30, 2025 10.04 Mn
Jun 30, 2025 10.04 Mn
Mar 31, 2025 955,000.00
Mar 31, 2025 955,000.00
Dec 31, 2024 8.44 Mn
Dec 31, 2024 8.44 Mn
Sep 30, 2024 24.34 Mn
Sep 30, 2024 24.34 Mn
Jun 30, 2024 16.97 Mn
Jun 30, 2024 16.97 Mn
Mar 31, 2024 3.70 Mn
Mar 31, 2024 3.70 Mn
Dec 31, 2023 5.46 Mn
Dec 31, 2023 5.46 Mn